Literature DB >> 14993838

Glycosylation defining cancer cell motility and invasiveness.

Masaya Ono1, Senitiroh Hakomori.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14993838     DOI: 10.1023/B:GLYC.0000018019.22070.7d

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   3.009


× No keyword cloud information.
  42 in total

1.  A close association of GM3 with c-Src and Rho in GM3-enriched microdomains at the B16 melanoma cell surface membrane: a preliminary note.

Authors:  S Yamamura; K Handa; S Hakomori
Journal:  Biochem Biophys Res Commun       Date:  1997-07-09       Impact factor: 3.575

Review 2.  The tetraspanin superfamily: molecular facilitators.

Authors:  H T Maecker; S C Todd; S Levy
Journal:  FASEB J       Date:  1997-05       Impact factor: 5.191

Review 3.  Analysis of the synthesis, intracellular sorting, and function of glycoproteins using a mammalian cell mutant with reversible glycosylation defects.

Authors:  M Krieger; P Reddy; K Kozarsky; D Kingsley; L Hobbie; M Penman
Journal:  Methods Cell Biol       Date:  1989       Impact factor: 1.441

4.  Association of MUC-1 and SPGL-1 with low-density microdomain in T-lymphocytes: a preliminary note.

Authors:  K Handa; F Jacobs; B M Longenecker; S I Hakomori
Journal:  Biochem Biophys Res Commun       Date:  2001-07-20       Impact factor: 3.575

5.  Negative regulation of neuroblastoma cell growth by carbohydrate-dependent surface binding of galectin-1 and functional divergence from galectin-3.

Authors:  J Kopitz; C von Reitzenstein; S André; H Kaltner; J Uhl; V Ehemann; M Cantz; H J Gabius
Journal:  J Biol Chem       Date:  2001-07-12       Impact factor: 5.157

6.  Motility inhibition and apoptosis are induced by metastasis-suppressing gene product CD82 and its analogue CD9, with concurrent glycosylation.

Authors:  M Ono; K Handa; D A Withers; S Hakomori
Journal:  Cancer Res       Date:  1999-05-15       Impact factor: 12.701

7.  Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study.

Authors:  S Nakamori; M Kameyama; S Imaoka; H Furukawa; O Ishikawa; Y Sasaki; T Kabuto; T Iwanaga; Y Matsushita; T Irimura
Journal:  Cancer Res       Date:  1993-08-01       Impact factor: 12.701

8.  Separation of "glycosphingolipid signaling domain" from caveolin-containing membrane fraction in mouse melanoma B16 cells and its role in cell adhesion coupled with signaling.

Authors:  K Iwabuchi; K Handa; S Hakomori
Journal:  J Biol Chem       Date:  1998-12-11       Impact factor: 5.157

9.  Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells.

Authors:  M Ono; K Handa; D A Withers; S Hakomori
Journal:  Biochem Biophys Res Commun       Date:  2000-12-29       Impact factor: 3.575

10.  Cell adhesion in a dynamic flow system as compared to static system. Glycosphingolipid-glycosphingolipid interaction in the dynamic system predominates over lectin- or integrin-based mechanisms in adhesion of B16 melanoma cells to non-activated endothelial cells.

Authors:  N Kojima; M Shiota; Y Sadahira; K Handa; S Hakomori
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

View more
  53 in total

Review 1.  Mass spectrometry based glycoproteomics--from a proteomics perspective.

Authors:  Sheng Pan; Ru Chen; Ruedi Aebersold; Teresa A Brentnall
Journal:  Mol Cell Proteomics       Date:  2010-08-24       Impact factor: 5.911

2.  An O-glycosyltransferase promotes cell adhesion during development by influencing secretion of an extracellular matrix integrin ligand.

Authors:  Liping Zhang; Duy T Tran; Kelly G Ten Hagen
Journal:  J Biol Chem       Date:  2010-04-06       Impact factor: 5.157

3.  Actin Filaments Are Involved in the Coupling of V0-V1 Domains of Vacuolar H+-ATPase at the Golgi Complex.

Authors:  Carla Serra-Peinado; Adrià Sicart; Juan Llopis; Gustavo Egea
Journal:  J Biol Chem       Date:  2016-02-12       Impact factor: 5.157

4.  Coronavirus and influenza virus proteolytic priming takes place in tetraspanin-enriched membrane microdomains.

Authors:  James T Earnest; Michael P Hantak; Jung-Eun Park; Tom Gallagher
Journal:  J Virol       Date:  2015-04-01       Impact factor: 5.103

Review 5.  Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.

Authors:  Maria Teresa Tarragó-Trani; Brian Storrie
Journal:  Adv Drug Deliv Rev       Date:  2007-06-28       Impact factor: 15.470

6.  Differential splicing of the lectin domain of an O-glycosyltransferase modulates both peptide and glycopeptide preferences.

Authors:  Carolyn May; Suena Ji; Zulfeqhar A Syed; Leslie Revoredo; Earnest James Paul Daniel; Thomas A Gerken; Lawrence A Tabak; Nadine L Samara; Kelly G Ten Hagen
Journal:  J Biol Chem       Date:  2020-07-15       Impact factor: 5.157

Review 7.  Mucin-type O-glycosylation during development.

Authors:  Duy T Tran; Kelly G Ten Hagen
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

8.  Implications on glycobiological aspects of tumor hypoxia in breast ductal carcinoma in situ.

Authors:  Moacyr Jesus Barreto de Melo Rêgo; Gabriela Souto Vieira de Mello; Carlos André da Silva Santos; Roger Chammas; Eduardo Isidoro Carneiro Beltrão
Journal:  Med Mol Morphol       Date:  2013-02-05       Impact factor: 2.309

9.  Moving a Carbohydrate Mimetic Peptide into the clinic.

Authors:  Issam Makhoul; Laura Hutchins; Peter D Emanuel; Angela Pennisi; Eric Siegel; Fariba Jousheghany; Behjatolah Monzavi-Karbassi; Thomas Kieber-Emmons
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

10.  Rad9 protein contributes to prostate tumor progression by promoting cell migration and anoikis resistance.

Authors:  Constantinos G Broustas; Aiping Zhu; Howard B Lieberman
Journal:  J Biol Chem       Date:  2012-10-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.